Risk Stratification in Hypertrophic Cardiomyopathy
Key result
Implantable cardioverter-defibrillators effectively prevent sudden cardiac death in hypertrophic cardiomyopathy, a disease with an overall annual mortality rate of <1%.
Population
Patients with hypertrophic cardiomyopathy (HCM)
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Emphasizes careful ICD selection in low-mortality HCM; leaves open refined risk stratification to minimize complications.
Structured PICO
P
Population
Patients with hypertrophic cardiomyopathy (HCM)
I
Intervention
Risk stratification for sudden cardiac death and ICD implantation
O
Outcome
Sudden cardiac death (SCD)
Accurate risk stratification is crucial in hypertrophic cardiomyopathy to ensure ICDs are implanted in high-risk patients while minimizing device-related complications in those at lower risk.
Limitations
- The new ESC risk model requires validation in different cohorts
- Complications associated with ICD therapy
Cite This Study
Steriotis et al. (2015) conducted a review in Hypertrophic cardiomyopathy. Implantable cardioverter-defibrillator (ICD) was evaluated. Implantable cardioverter-defibrillators effectively prevent sudden cardiac death in hypertrophic cardiomyopathy, a disease with an overall annual mortality rate of <1%.